Celularity
CELU
Celularity (CELU) earnings history
Most recent quarter
- Fiscal period
- Q4 2022
- Period end
- Dec 31, 2022
- EPS actual
- $1.50
- EPS estimate
- −$2.54
- EPS surprise
- +159.06%
- Revenue surprise
- −24.76%
- Revenue
- $4.1M
- Revenue estimate
- $5.5M
- Reported
- Mar 31, 2023
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2022 | Mar 31, 2023 | −$2.54 | $1.50 | +159.06% | $4.1M | SEC |
| Q3 2022 | Nov 10, 2022 | −$2.62 | $0.30 | +111.46% | $4.1M | — |
| Q2 2022 | Aug 9, 2022 | −$2.61 | $3.20 | +222.50% | $3.8M | SEC |
| Q1 2022 | May 16, 2022 | −$2.27 | −$4.80 | −111.76% | $5.9M | SEC |
| Q4 2021 | Mar 31, 2022 | −$3.11 | −$0.30 | +90.34% | $4.9M | SEC |
| Q3 2021 | Nov 12, 2021 | −$3.45 | $4.00 | +215.94% | $10.6M | SEC |
| Q2 2021 | Aug 16, 2021 | −$1.63 | −$26.90 | −1554.37% | $3.2M | — |
Quarterly revenue
Frequently asked questions
When did Celularity (CELU) last report earnings?
Celularity last reported on Mar 31, 2023, covering fiscal Q4 2022.
Did CELU beat earnings estimates?
Yes. Celularity reported EPS of $1.50 for Q4 2022 against a −$2.54 estimate — a 159.06% beat.
How much revenue did CELU report last quarter?
Celularity reported $4.1M in revenue for Q4 2022, against a consensus estimate of $5.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.